Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF CASH FLOWS

v3.22.2.2
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Cash Flows from Operating Activities:        
Net income     $ 8,827,622 $ 13,248,147
Adjustments to reconcile net income to net cash used in operating activities:        
Change in fair value of warrant liabilities $ (898,333) $ (5,749,333) (9,522,333) (15,271,666)
Interest earned on investments held in Trust Account (1,404,404) (4,955) (1,893,677) (29,631)
Transaction costs incurred in connection with derivative warrant liabilities       974,164
Changes in operating assets and liabilities:        
Prepaid expenses     (232,314) 491,583
Accounts payable and accrued expenses     1,290,856 778,852
Net cash used in operating activities     (1,065,218) (791,717)
Cash Flows from Investing Activities:        
Investment of cash in Trust Account       (345,000,000)
Net cash used in investing activities       (345,000,000)
Cash Flows from Financing Activities:        
Proceeds from sale of Units, net of underwriting discounts paid       338,100,000
Proceeds from sale of Private Placement Warrants       9,700,000
Advances from related party     9,533  
Repayment of promissory note - related party       (89,889)
Payment of offering costs       (486,260)
Net cash provided by financing activities     9,533 347,223,851
Net Change in Cash     (1,055,685) 1,432,134
Cash - Beginning of period     1,223,657  
Cash - End of period $ 167,972 $ 1,432,134 $ 167,972 1,432,134
Non-Cash investing and financing activities:        
Offering costs included in accrued offering costs       375,000
Offering costs paid through promissory note       89,889
Deferred underwriting fee payable       $ 12,075,000